Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market on May 20, 2024 Get link Facebook X Pinterest Email Other Apps from Science News - Times of India https://ift.tt/YedQGNb via Comments
Comments
Post a Comment